One mouse of genotype Rosa26_Alkal2;Th-MYCN was identified with an abdominal tumour (∅ > 14 mm) 100 days after initial treatment start and subjected to an additional 14 day regimen, exhibiting a second complete response (Supplementary Fig. 6). This evidence concerns the gene MYCN and neoplasm.